BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15552380)

  • 1. Erectile dysfunction.
    Wooten JM
    RN; 2004 Oct; 67(10):40-5; quiz 46. PubMed ID: 15552380
    [No Abstract]   [Full Text] [Related]  

  • 2. Pills for erectile dysfunction: now there are three.
    Harv Mens Health Watch; 2004 Apr; 8(9):5-6. PubMed ID: 15100064
    [No Abstract]   [Full Text] [Related]  

  • 3. Tadalafil (Cialis) and vardenafil (Levitra) recently approved drugs for erectile dysfunction.
    Gaines KK
    Urol Nurs; 2004 Feb; 24(1):46-8. PubMed ID: 15054911
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract]   [Full Text] [Related]  

  • 5. Erectile dysfunction: the Viagra revolution.
    Harv Mens Health Watch; 2005 Apr; 9(9):1-6. PubMed ID: 18217258
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond Viagra. What are your options?
    Mayo Clin Health Lett; 2006 Jan; 24(1):7. PubMed ID: 16468157
    [No Abstract]   [Full Text] [Related]  

  • 7. Erectile dysfunction.
    Harv Mens Health Watch; 2006 Aug; 11(1):3-4. PubMed ID: 17128442
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of erectile dysfunction].
    Romics I
    Orv Hetil; 2004 Feb; 145(9):491-3. PubMed ID: 15077482
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erectile dysfunction (ED) and diabetes mellitus].
    Takahashi Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():553-7. PubMed ID: 15999768
    [No Abstract]   [Full Text] [Related]  

  • 10. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
    Mason RG
    J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men.
    Soler JM; Previnaire JG; Denys P; Chartier-Kastler E
    Spinal Cord; 2007 Feb; 45(2):169-73. PubMed ID: 16801935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction.
    Shabsigh R; Seftel AD; Rosen RC; Porst H; Ahuja S; Deeley MC; Garcia CS; Giuliano F
    Urology; 2006 Oct; 68(4):689-96. PubMed ID: 17070333
    [No Abstract]   [Full Text] [Related]  

  • 13. [Viagra -- patients stand by their treatment].
    Praxis (Bern 1994); 2006 Nov; 95(47):1835-6. PubMed ID: 17168079
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual loss with erectile dysfunction medications.
    Wooltorton E
    CMAJ; 2006 Aug; 175(4):355. PubMed ID: 16870715
    [No Abstract]   [Full Text] [Related]  

  • 15. US advertising campaign begins for alternative to sildenafil.
    Josefson D
    BMJ; 2003 Aug; 327(7413):468. PubMed ID: 12946961
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of erectile dysfunction after radical retropubic prostatectomy with PDE5 inhibitor].
    Jin W; Huang YR
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):708-12. PubMed ID: 16209216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE-5 inhibitors: current status and future trends.
    Masson P; Lambert SM; Brown M; Shabsigh R
    Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of erectile dysfunction].
    Kopa Z; Romics I
    Orv Hetil; 2010 Feb; 151(9):354-7. PubMed ID: 20159751
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies.
    McCullough A
    Curr Urol Rep; 2004 Dec; 5(6):451-9. PubMed ID: 15541215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phosphodiesterase inhibitors: effectiveness and new applications].
    van Driel MF
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1613-6. PubMed ID: 16901064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.